New web tool aims to keep Low-Risk prostate cancer patients on track
NCT ID NCT05764005
First seen Mar 13, 2026 · Last updated May 25, 2026 · Updated 11 times
Summary
This pilot study tested a web-based tool called MAP to help men aged 55+ with low-risk prostate cancer stay on active surveillance. The tool provides information and reminders about needed tests and how their primary care doctor can help. The study enrolled 39 men and measured how well the tool worked and how satisfied patients were.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Michigan Rogel Cancer Center
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.